TipRanks
Advertisement
Advertisement
Delcath Systems sees positive adjusted EBITDA in FY26
PremiumThe FlyDelcath Systems sees positive adjusted EBITDA in FY26
3M ago
Delcath: Buy Rating Reiterated as CHOPIN Data and Commercial Execution Support Unchanged $30 Price Target
Premium
Ratings
Delcath: Buy Rating Reiterated as CHOPIN Data and Commercial Execution Support Unchanged $30 Price Target
3M ago
DCTH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
DCTH Upcoming Earnings Report: What to Expect?
3M ago
Delcath Systems Balances Growth with Rising Costs
PremiumCompany AnnouncementsDelcath Systems Balances Growth with Rising Costs
6M ago
Delcath Systems presents new data on M-PHP at ESMO
Premium
The Fly
Delcath Systems presents new data on M-PHP at ESMO
6M ago
Delcath Systems reports Q1 EPS (3c), consensus (9c)
Premium
The Fly
Delcath Systems reports Q1 EPS (3c), consensus (9c)
6M ago
Delcath Systems Charts Profitable Path Amid Heavy Investment
PremiumCompany AnnouncementsDelcath Systems Charts Profitable Path Amid Heavy Investment
8M ago
Delcath Highlights CHOPIN Phase 2 Results in Uveal Melanoma
Premium
Company Announcements
Delcath Highlights CHOPIN Phase 2 Results in Uveal Melanoma
8M ago
Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology
Premium
The Fly
Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology
8M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―